Pain Medication and Pain Intensity Following Hip Fractures—Analyses Based on the <scp>ProFem</scp> Cohort Study
As a substantial number of patients reports high intensity pain about 3 months following a PFF, the large proportion of those receiving no or only PRN pain medication raises questions regarding the appropriateness of the therapy. The overall low utilization of the BMP indicates potential for improvement.
Authors
- Kathrin Jobski (ORCID: https://orcid.org/0000-0002-3957-9721)
- Silke Andrich (ORCID: https://orcid.org/0000-0001-8884-7465)
- Joachim Windolf
- Birgit Klüppelholz
- Michaela Ritschel (ORCID: https://orcid.org/0000-0001-8686-7956)
- Simon Thelen (ORCID: https://orcid.org/0000-0003-1852-5748)
- Astrid Stephan (ORCID: https://orcid.org/0000-0002-5068-918X)
- Burkhard Haastert (ORCID: https://orcid.org/0000-0002-5108-158X)
- Veronika Gontscharuk (ORCID: https://orcid.org/0000-0002-6306-8454)
- Falk Hoffmann (ORCID: https://orcid.org/0000-0003-0182-5373)
- Gabriele Meyer (ORCID: https://orcid.org/0000-0002-3188-2902)
- Marion Baltes (ORCID: https://orcid.org/0000-0003-2246-9793)
- Katja Pöggel‐Krämer
- Andrea Icks (ORCID: https://orcid.org/0000-0001-8471-3785)
- Daniela Anheier
- Werner Arend
- Carina Jaekel
Institutions
- Carl von Ossietzky Universität Oldenburg (DE)
- Düsseldorf University Hospital (DE)
- Universitätsklinikum Aachen (DE)
- Deutsches Diabetes-Zentrum e.V. (DE)
- Heinrich Heine University Düsseldorf (DE)
- Martin Luther University Halle-Wittenberg (DE)
Publication Details
- Journal
- Pharmacoepidemiology and Drug Safety
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1002/pds.5865
- Primary Topic
- Hip and Femur Fractures
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Gemeinsame Bundesausschuss